Stock listing

Minerva Neurosciences, Inc

Selected listing: NERV · NASDAQ · USD · US

Minerva Neurosciences, Inc (NASDAQ:NERV), Health Technology. Latest release Aug 28, 2026: Minerva Neurosciences to Participate in Two Upcoming Investor…

NERV:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:NERV
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Minerva Neurosciences, Inc

Minerva Neurosciences, Inc. is a public company traded under the ticker NERV in the American market. Minerva focuses on developing innovative therapies for neuropsychiatric diseases.

Latest news from Minerva Neurosciences, Inc

Minerva Neurosciences to Participate in Two Upcoming Investor Conferences

August 28, 2026

Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates

August 7, 2026

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

June 1, 2026

Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference

May 18, 2026

Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates

May 5, 2026

All Minerva Neurosciences, Inc news →

Events

Replays

Minerva Neurosciences, Inc (NERV) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 07:00 AM ET
Watch
Minerva Neurosciences, Inc (NERV) Q1 2023 Earnings Call
Mon, May 15, 2023 · 08:30 AM ET
Watch
Minerva Neurosciences, Inc (NERV) Q4 2022 Earnings Call
Wed, Mar 08, 2023 · 08:30 AM ET
Watch

Research Minerva Neurosciences, Inc

Minerva Neurosciences, Inc company profile

View the public company page for Minerva Neurosciences, Inc on 6ix.

Minerva Neurosciences, Inc news

Read company news and market updates connected to Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc investor events

Find investor webinars, events, and replay context for Minerva Neurosciences, Inc.